Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Inclusion Criteria: * Patients enrolled on phase 1 of the study are eligible (and/or if recruited from tumor registry or clinic follow-up schedules) * Diagnosed with invasive malignancy including: breast, gastrointestinal track, female or male genitourinary system, sarcoma of bone or soft-tissue, leukemia and lymphoma * Treated at one of the Survivorship Centers of Excellence or their community affiliates * Received a therapeutic intervention with at least one of the following modalities: surgery, cytotoxic chemotherapy, biological or targeted agents, radiation therapy (any modality) * Currently between 1.0 and 4.99 years from the completion of active cancer-directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) * Patient must still be in active follow-up: seen for a follow-up visit in the participating center at least once in the 3 years prior to enrollment and/or scheduled to be seen for follow-up in the next 6 months (i.e. in active follow-up) * May be receiving "maintenance" therapy that has a goal of prevention of recurrence but there should be no expectations for further active treatment * Able to read and speak English adequate to complete the patient-reported outcomes (PRO) assessment Exclusion Criteria: * Prior visit to a survivorship clinic or previously provided with a treatment summary and care plan